Maximus, Inc. (NYSE:MMS) President Bruce Caswell sold 8,000 shares of the company’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $63.56, for a total value of $508,480.00. Following the sale, the president now owns 35,904 shares of the company’s stock, valued at approximately $2,282,058.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Bruce Caswell also recently made the following trade(s):

  • On Monday, June 5th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $63.48, for a total value of $507,840.00.
  • On Tuesday, May 23rd, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $62.76, for a total value of $502,080.00.
  • On Thursday, May 18th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $61.79, for a total value of $494,320.00.
  • On Thursday, May 11th, Bruce Caswell sold 17,197 shares of Maximus stock. The stock was sold at an average price of $62.47, for a total value of $1,074,296.59.

Maximus, Inc. (NYSE MMS) traded up 1.07% during trading on Monday, hitting $64.44. The company had a trading volume of 137,747 shares. The stock has a market capitalization of $4.18 billion, a price-to-earnings ratio of 21.13 and a beta of 1.45. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $64.97. The firm’s 50 day moving average is $62.76 and its 200-day moving average is $59.31.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 4th. The health services provider reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.02. Maximus had a net margin of 8.18% and a return on equity of 26.21%. The company had revenue of $622 million for the quarter, compared to analyst estimates of $620.24 million. During the same period in the previous year, the business posted $0.74 earnings per share. Maximus’s quarterly revenue was up 2.6% on a year-over-year basis. On average, equities analysts forecast that Maximus, Inc. will post $3.05 earnings per share for the current year.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 31st. Shareholders of record on Monday, May 15th were issued a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend was Thursday, May 11th. Maximus’s dividend payout ratio (DPR) is presently 5.86%.

COPYRIGHT VIOLATION WARNING: “Insider Selling: Maximus, Inc. (MMS) President Sells 8,000 Shares of Stock” was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/06/19/insider-selling-maximus-inc-mms-president-sells-8000-shares-of-stock.html.

Several hedge funds have recently made changes to their positions in the stock. Bank of Montreal Can increased its stake in shares of Maximus by 56.5% in the first quarter. Bank of Montreal Can now owns 125,084 shares of the health services provider’s stock valued at $7,780,000 after buying an additional 45,167 shares during the period. WCM Investment Management CA raised its position in shares of Maximus by 7.5% in the first quarter. WCM Investment Management CA now owns 24,411 shares of the health services provider’s stock valued at $1,518,000 after buying an additional 1,700 shares during the period. Norges Bank bought a new position in shares of Maximus during the fourth quarter valued at approximately $25,597,000. Thrivent Financial for Lutherans raised its position in shares of Maximus by 2.5% in the fourth quarter. Thrivent Financial for Lutherans now owns 43,670 shares of the health services provider’s stock valued at $2,436,000 after buying an additional 1,070 shares during the period. Finally, Tudor Investment Corp Et Al raised its position in shares of Maximus by 177.7% in the fourth quarter. Tudor Investment Corp Et Al now owns 10,279 shares of the health services provider’s stock valued at $573,000 after buying an additional 6,578 shares during the period. 98.67% of the stock is currently owned by institutional investors.

MMS has been the subject of a number of analyst reports. Canaccord Genuity restated a “buy” rating and set a $62.00 target price on shares of Maximus in a report on Friday, April 7th. Maxim Group downgraded Maximus from a “buy” rating to a “hold” rating and set a $66.00 price target on the stock. in a research report on Thursday, May 4th. They noted that the move was a valuation call. Jefferies Group LLC downgraded Maximus from a “buy” rating to a “hold” rating and upped their price target for the stock from $63.00 to $64.00 in a research report on Friday, May 5th. ValuEngine downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Tuesday, May 16th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. One analyst has rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $61.33.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.